Novartis
Senior Principal Scientist/Principal Scientist, Immune Engagers
$126K–$246K
Cambridge (USA) · Principal · Full-time · Posted Oct 26, 2026
- Experience
- 5+ years of relevant research and/or industry experience with a PhD; or 10+ years of relevant industry experience with an MS.
- Education
- PhD in cancer biology, immunology, or a related discipline; or MS.
About the job
Leads biology and drug-discovery programs for immune cell engagers and multispecific immune modulators, advancing cancer therapies from target validation toward clinical development.
What you'll do
- Identify and validate tumor-targeting strategies and lead biology strategy and execution for multidisciplinary discovery programs.
- Design and interpret mechanistic studies, integrate cross-functional perspectives, and present evidence-based recommendations at governance reviews.
- Lead and develop scientists, build collaborations, and contribute to immune-engager strategy and modality innovation.
What they ask for
- PhD in cancer biology, immunology, or a related discipline with 5+ years of relevant research and/or industry experience; or MS with 10+ years of relevant industry experience.
- Expertise in cancer biology and/or immunology, including tumor immunology, T-cell or myeloid-cell biology, and immune suppression in the tumor microenvironment.
- Proficiency in immune-cell functional assays and complex immunophenotyping, including in vitro and ex vivo assays and multiparameter flow cytometry.
- Experience in antibody, multispecific biologic, and/or immune-engager discovery within cross-functional teams; strong research publication track record.
Nice to have
- Leadership in T-cell or myeloid cell-engager discovery from target validation through IND-enabling or early clinical activities.
- Project-team leadership, next-generation engager innovation, and mentoring experience.
Pay
$126,000 - $234,000 per year (base salary); $132,300 - $245,700 per year (base salary)
Tools
multiparameter flow cytometry
Model-written summary · the original posting is authoritative